Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 3/20 | 0.82 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.65 |
| ▸ | DPP4 | P27487 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.65 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.65 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.65 |
| ▸ | GAPDH | P04406 | 1/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.65 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.65 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.65 |
| ▸ | STAT6 | P42226 | 1/20 | 0.65 |
| ▸ | PI4KA | P42356 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.65 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.65 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tubercidin SCHEMBL11289302 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL11239877 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL8259 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL23351430 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL20419325 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL23982115 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL20419149 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL23982350 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL20938187 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 | |
| Tubercidin SCHEMBL1739818 | 1.00 | ADK (0.82) | ADKSLC29A1DPP4MEN1SLC28A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026086871-A1 | ANTI-AGEING COMPOUNDS, USES THEREFOR, METHOD FOR IDENTIFYING, AND COMPOSITIONS CONTAINING | Centre for Translational Stem Cell Biology Limited (CN) | 2026-04-30 | — | — | WO | disclosed |
| CN-121129880-A | Application of compound six as proteasome inhibitor | 中南大学湘雅二医院 | 2025-12-16 | — | — | CN | disclosed |
| EP-4603099-A1 | ANTI-INFLUENZA VIRUS COMPOSITION, MEDICINE, FOOD, BEVERAGE, SUPPLEMENT, AGRICULTURAL CHEMICAL, FEED AND COSMETIC | Igarashi, Manabu (JP) | 2025-08-20 | — | — | EP | disclosed |
| CN-120157727-A | Chemically modified adenine nucleoside triphosphate and preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2025-06-17 | — | — | CN | disclosed |
| WO-2024250923-A1 | CHEMICALLY MODIFIED NUCLEOSIDE, CHEMICALLY MODIFIED NUCLEOSIDE TRIPHOSPHATE AND USE THEREOF | 中国科学院深圳先进技术研究院 | 2024-12-12 | — | — | WO | disclosed |
| CN-114259501-B | Application of tuberculin to preparation of bacteriostat of mycobacterium abscessus and/or mycobacterium tuberculosis | 首都医科大学附属北京胸科医院 | 2024-09-13 | — | — | CN | disclosed |
| US-20240131046-A1 | ANTI-VIRAL AGENT | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2024-04-25 | — | — | US | disclosed |
| WO-2024075794-A1 | ANTI-INFLUENZA VIRUS COMPOSITION, MEDICINE, FOOD, BEVERAGE, SUPPLEMENT, AGRICULTURAL CHEMICAL, FEED AND COSMETIC | 国立大学法人北海道大学 | 2024-04-11 | — | — | WO | disclosed |
| EP-4282420-A1 | ANTI-VIRAL AGENT | National University Corporation Hokkaido University (JP) | 2023-11-29 | — | — | EP | disclosed |
| CN-116761615-A | antiviral agent | 国立大学法人北海道大学 | 2023-09-15 | — | — | CN | disclosed |
| WO-2022158528-A1 | ANTI-VIRAL AGENT | 国立大学法人北海道大学 | 2022-07-28 | — | — | WO | disclosed |
| CN-114259501-A | Application of tubercidin in preparation of bacteriostat for mycobacterium abscessus and/or mycobacterium tuberculosis | 首都医科大学附属北京胸科医院 | 2022-04-01 | — | — | CN | disclosed |
| US-20210338706-A1 | ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2021-11-04 | — | — | US | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131046-A1 | ANTI-VIRAL AGENT | SARS1, ACE2, ZC3HAV1 | ADK 4790/4885SLC29A1 2305/4885DPP4 1089/4885 |
| US-20210338706-A1 | ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK | PER2, CRY1, ADORA2A | ADK 4/4885SLC29A1 450/4885DPP4 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.